Doyenne Group
Madison, United States1
5K
1
0.10
- Areas of investment
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.10
- Investments by industry
- Social Network (1)
- Video (1)
- Service Industry (1)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Captain T Cell | Nov 17, 2025 | Biotechnology, Immuno-oncology, TCR-T cell therapies, TGF-β switch receptor | - | 20000000 EUR |  Berlin, |
| Captain T Cell | Nov 17, 2025 | Biotechnology, Immuno-oncology, TCR-T cell therapies | - | 20000000 EUR | Berlin |
| HeartBeat.bio | Nov 3, 2023 | AI, Biotech, Drug Discovery, Heart Disease | Early stage | 4500000 EUR |  Vienna |
| Sampling Human | Apr 18, 2022 | Cell Diagnostics Technology, Diagnostics, Liquid Biopsy, Synthetic Biology | - | 2000000 USD | San Diego, California |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.